Wetzlar, Germany. At the Congress of Neurological Surgeons (CNS) Annual Meeting 2017, Boston, USA, Leica Microsystems will showcase its new groundbreaking GLOW augmented reality (AR) platform featuring the latest innovation in vascular fluorescence imaging: GLOW800 AR fluorescence. Visitors to the booth will also be able to experience FL560 fluorescence, the first FDA 510(k) cleared microscope filter for vascular fluorescence with fluorescein and FL400 the first blue light fluorescence available as a FDA Class I device.
GLOW800 AR fluorescence allows neurosurgeons to observe both the naturally-colored cerebral anatomy and highlighted vascular blood flow in one single augmented, real-time view with full depth perception. The surgeon thus has a complete view of anatomy and physiology to support crucial decisions and actions during vascular neurosurgery.
"For the past decade Leica Microsystems has been pioneering new fluorescence imaging technologies in partnership with surgeons to advance surgical practices" says Markus Lusser, President of Leica Microsystems. "GLOW800 and future modalities based on the GLOW AR platform will allow surgeons to perform life-changing neurosurgical interventions with the confidence that they have the best possible visual information right in the field of view."
Until now, viewing blood flow with Indocyanine Green (ICG) fluorescent agent meant pausing surgery to watch a separate near infrared (